These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26259643)
1. Influence of echinocandin administration on hemodynamic parameters in medical intensive care unit patients: a single center prospective study. Lahmer T; Schnappauf C; Messer M; Rasch S; Fekecs L; Beitz A; Eser S; Schmid RM; Huber W Infection; 2015 Dec; 43(6):723-7. PubMed ID: 26259643 [TBL] [Abstract][Full Text] [Related]
2. Cardiac effects of echinocandin preparations - three case reports. Lichtenstern C; Wolff M; Arens C; Klie F; Majeed RW; Henrich M; Uhle F; Weiterer S; Röhrig R; Weigand MA J Clin Pharm Ther; 2013 Oct; 38(5):429-31. PubMed ID: 23815256 [TBL] [Abstract][Full Text] [Related]
3. Hemodynamic changes in surgical intensive care unit patients undergoing echinocandin treatment. Koch C; Schneck E; Arens C; Markmann M; Sander M; Henrich M; Weigand MA; Lichtenstern C Int J Clin Pharm; 2020 Feb; 42(1):72-79. PubMed ID: 31748967 [TBL] [Abstract][Full Text] [Related]
4. Cardiac effects of echinocandins after central venous administration in adult rats. Koch C; Uhle F; Wolff M; Arens C; Schulte A; Li L; Niemann B; Henrich M; Rohrbach S; Weigand MA; Lichtenstern C Antimicrob Agents Chemother; 2015 Mar; 59(3):1612-9. PubMed ID: 25547351 [TBL] [Abstract][Full Text] [Related]
5. Echinocandin use in the neonatal intensive care unit. Caudle KE; Inger AG; Butler DR; Rogers PD Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252 [TBL] [Abstract][Full Text] [Related]
6. Influence of volume administration on Doppler-based renal resistive index, renal hemodynamics and renal function in medical intensive care unit patients with septic-induced acute kidney injury: a pilot study. Lahmer T; Rasch S; Schnappauf C; Schmid RM; Huber W Int Urol Nephrol; 2016 Aug; 48(8):1327-1334. PubMed ID: 27193438 [TBL] [Abstract][Full Text] [Related]
7. Cardiac toxicity of the echinocandins: chance or cause and effect association? Stover KR; King ST; Cleary JD J Clin Pharm Ther; 2014 Feb; 39(1):1-3. PubMed ID: 24383937 [TBL] [Abstract][Full Text] [Related]
8. A severe case of haemodynamic instability during anidulafungin administration. Fink M; Zerlauth U; Kaulfersch C; Rab A; Alberer D; Preiss P; Sternad-Klobschauer K; Habernig E; Wandschneider W; Grimm G J Clin Pharm Ther; 2013 Jun; 38(3):241-2. PubMed ID: 23550735 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of caspofungin in critically ill patients. ProCAS Study. León-Gil C; Ubeda-Iglesias A; Loza-Vázquez A; de la Torre MV; Raurich-Puigdevall JM; Alvarez-Sánchez B; Ortiz-Leyva C; Domínguez-Roldán JM; Socías-Crespi L; Garnacho-Montero J; Rev Esp Quimioter; 2012 Dec; 25(4):274-82. PubMed ID: 23303260 [TBL] [Abstract][Full Text] [Related]
10. Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU. Bruyère R; Quenot JP; Prin S; Dalle F; Vigneron C; Aho S; Leon C; Charles PE BMC Infect Dis; 2014 Jul; 14():385. PubMed ID: 25015848 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic/pharmacodynamics variability of echinocandins in critically ill patients: A systematic review and meta-analysis. Liu X; Liu D; Pan Y; Li Y J Clin Pharm Ther; 2020 Dec; 45(6):1207-1217. PubMed ID: 32672361 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of caspofungin in ICU patients. Muilwijk EW; Schouten JA; van Leeuwen HJ; van Zanten AR; de Lange DW; Colbers A; Verweij PE; Burger DM; Pickkers P; Brüggemann RJ J Antimicrob Chemother; 2014 Dec; 69(12):3294-9. PubMed ID: 25139840 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Transpulmonary Thermodilution Data Confirms the Influence of Renal Replacement Therapy on Thermodilution Hemodynamic Measurements. Schmidt S; Westhoff T; Schlattmann P; Zidek W; Compton F Anesth Analg; 2016 May; 122(5):1474-9. PubMed ID: 26928634 [TBL] [Abstract][Full Text] [Related]
14. Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: A post-hoc causal inference model using the AmarCAND2 study. Bailly S; Leroy O; Azoulay E; Montravers P; Constantin JM; Dupont H; Guillemot D; Lortholary O; Mira JP; Perrigault PF; Gangneux JP; Timsit JF; J Infect; 2017 Apr; 74(4):408-417. PubMed ID: 28104387 [TBL] [Abstract][Full Text] [Related]
15. Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections. van der Geest PJ; Rijnders BJ; Vonk AG; Groeneveld AB Mycoses; 2016 Mar; 59(3):179-85. PubMed ID: 26707572 [TBL] [Abstract][Full Text] [Related]
16. Physical examination, central venous pressure, and chest radiography for the prediction of transpulmonary thermodilution-derived hemodynamic parameters in critically ill patients: a prospective trial. Saugel B; Ringmaier S; Holzapfel K; Schuster T; Phillip V; Schmid RM; Huber W J Crit Care; 2011 Aug; 26(4):402-10. PubMed ID: 21273034 [TBL] [Abstract][Full Text] [Related]
17. Noninvasive cardiac output determination using applanation tonometry-derived radial artery pulse contour analysis in critically ill patients. Compton F; Wittrock M; Schaefer JH; Zidek W; Tepel M; Scholze A Anesth Analg; 2008 Jan; 106(1):171-4, table of contents. PubMed ID: 18165574 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of anidulafungin in elderly, critically ill patients with invasive Candida infections: a post hoc analysis. Dimopoulos G; Paiva JA; Meersseman W; Pachl J; Grigoras I; Sganga G; Montravers P; Auzinger G; Sá MB; Miller PJ; Marček T; Kantecki M; Ruhnke M Int J Antimicrob Agents; 2012 Dec; 40(6):521-6. PubMed ID: 22998997 [TBL] [Abstract][Full Text] [Related]
19. Impact of Therapeutic Plasma Exchange on Hemodynamic Parameters in Medical Intensive Care Unit Patients: An Observational Study. Lahmer T; Messer M; Schnappauf C; Rasch S; Fekecs L; Beitz A; Eser S; Schmid RM; Huber W Artif Organs; 2017 Feb; 41(2):204-209. PubMed ID: 27121592 [TBL] [Abstract][Full Text] [Related]
20. Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data. Bailly S; Leroy O; Montravers P; Constantin JM; Dupont H; Guillemot D; Lortholary O; Mira JP; Perrigault PF; Gangneux JP; Azoulay E; Timsit JF Intensive Care Med; 2015 Nov; 41(11):1931-40. PubMed ID: 26370688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]